Infleunza Part2 Wk4 Flashcards

1
Q

Transcription of virus mRNAs use fragment of cellular mRNA
Cellular mRNA transcription

A
  • rapid addition of 5’ universal gap
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Influenza virus polymerase complex is bound to every genome segment

A

PB2 protein binds the 5’-cap of cellular mRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PB1 & PA proteins work in concert as an endonuclease

A

= cleaves capped RNA (~10-15nt from the cap)
cap snatching

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Influenza virus polymerase complex

A

PB1 binds to both
-mRNA fragment with 5’-cap
-3’-end of genomic vRNA
=polymerase function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PB1 protein transcribes (+)ssRNA using

A

-mRNA fragments (with 5’-cap) as a primer
-genomic vRNA as a template

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

On reaching 5’end of vRNA template
(=3’end of the new (+)RNA)

A

The PB1 polymerase produces a polyA tail by reiterative stuttering
=repeated transcription on a short polyUTP sequence in the vRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Results of transcription = capped, polyadenylated chimeric mRNAs

A

5’-region is a fragment of cellular mRNA
Remainder is (+)ssRNA copy of (-)vRNA
5’-cap & polyA tail promote
-exit from cell nucleus
-translation by cell ribosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Influenza A virus replication cycle - genome replication
Is also RNA transcription but doesnt involve cap-snatching

A

Free rNTPs bind to the 3’-end of each of the cRNAs
PB1 polymerase protein forms a phosphodiester bond
PB1 transcribes (-)ssRNA from this dinucleotide primer
No 5’-cap is added - this is cRNA, not mRNA
(+) sense cRNA intermediates associated with with NP and polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A virus replication cycle - assembly & genome packaging
vRNAs & cRNAs associate with PB1, PB2, PA & NP in nucleus

A

Only vRNPs exit the nucleus - mediated through binding with M1 & NS2 proteins
M1 interacts with structual virus proteins at the plasma membrane
Plasma membrane & matrix layer wrap around vRNPs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Random / selective incorporation model

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Influenza A replication cycle - budding release

A

Exit by budding - gains envelops
Neuraminidase cleaves bonds
Also prevents virion aggregation
HA on new virions binds neuraminidase acids
On other virions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Neuraminidase protein is a targets for antiviral drugs

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Influenza virus pathogenesis
Acut, contagious infections of upper respiratory tract

A

-virus shed into respiratory lumen
-no systemic spread
-immune pathology
-self-limiting (strong immunity)
Fatalities rare
-elderly, young, immune-compromised
-viral / bacterial pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Influenza virus epidemics and pandemics

A

Seasonal recurrence of flu epidemics
-pandemic outbreaks also recorded through history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Influenza A virus genetic diversity, change + exchange

A

Advantageous mutations in human influenza/avian or swine influenza virus strains = new combinations of genome segments between human, avian & swine influenza virus strains.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Antigenic drift -selection due to immune pressure
Advantageous mutations occur over time, driving immune resistance

A

Protein antibody response. outcome
HA neutralising block infection, protective
NA non-neutralising. ADCC, curtail infection
M2, NP non- neutralising ADCC curtail infection, protective

17
Q

Antigenic drink - cause of 1918 pandemic and 2013 outbreak

A

1918 H1N1 - avian virus HA mutations = expanded binding to a-2,6 AND a-2,3 galactose-sialic acid
2013 H7N9 - HA and PB2 mutations allow binding & efficient replication in human cells

18
Q

Antigenic shift- reassortment of genome fragments

A

Influenza A viruses infect humans, mammals + birds
-miltiple virus types can infect individual hosts
-mixing of human, avian and swine virus genomes occurs
Significant intermediate (mixing) hosts = pigs, domestic birds, waterfowl

19
Q

Antigenic shift - reassortment of genome fragments

A

-2 or more virus subtypes infect single cell
-both/all virus genomes replicate in same nucleus
= assembly of virions
-mixed packaging of genome segments from each original virus
= reassortment / antigenic shift
Novel combinations of virus genomes = reassortants
H/N combinations significant

20
Q

Antigenic shift = cause of 1957 pandemic

A

Antigenic drift of avian H1N1 virus
Humanised over several decades
1957 pandemic = reassortment with avian H2N2 virus
New HA, NA, PB1

21
Q

Antigenic shift = cause of 1968 pandemic

A

1957 H2N2 virus = reassortment with avian
H2 virus
(New HA, PB1)
(Same NA2)

22
Q

Antigenic shift = cause of 2009 “swine flu” outbreak

A

First reassortment
=triple reassortment between avian, swine H1N1 & the 1968 H3N2 Hong Kong viruses

23
Q

Second reassortment

A

Between “new” swine H3N2 (triple reassortment) with classical swine H1N1

24
Q

Third assortment

A

Reassortment with the “new” swine H1N2 & another H1N1 swine virus

25
Antigenic shift= cause of 2013 “bird flu” outbreak
H7N9 reassortment involving 3 avian viruses Exchange steps unknown Domestic ducks H7N3 - wild birds H7N9 - domestic poultry Multiple H9N2 viruses
26
Influenza A vaccines
Annual - rely on year-round, world-wide surveillance of subtypes WHO- global influenza program CDC - us influenza surveillance report UDCD - European influenza surveillance network North hemisphere feb South hemisphere sep
27
Flucelvax (Novartis)
Whole virus (inactivated) Prepared in cell cultures Injection formulation
28
Flublok (Protein Sciences)
Recombinant HA protein HA gene cloned into baculovirus Prepared in infected insect cell cultures
29
Flumist (Medimmune / Astra Zeneca)
Attenuated “live” virus Prepared in infected hens eggs and chick cell cultures
30
Multitalented nucleoside-modified mRNA vaccine against all known influenza virus subtypes
20 strains represented mRNA vaccine - HA antigens Vaccination led to Antibody development against all 20 strains in mice & ferrets Reduced symptoms after lethal virus challenge Increase survival after lethal virus challenge